Hepatitis E medical therapy: Difference between revisions
Varun Kumar (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Hepatitis E}} | {{Hepatitis E}} | ||
{{CMG}} | {{CMG}} | ||
Line 16: | Line 17: | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Needs overview]] | |||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} |
Revision as of 19:32, 4 December 2012
Hepatitis E Microchapters |
Diagnosis |
---|
Treatment |
Hepatitis E medical therapy On the Web |
American Roentgen Ray Society Images of Hepatitis E medical therapy |
Risk calculators and risk factors for Hepatitis E medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
Hepatitis E is a viral disease, and as such, antibiotics are of no value in the treatment of the infection. There is no hyperimmune E globulin available for pre- or post-exposure prophylaxis. HEV infections are usually self-limited, and hospitalization is generally not required. No available therapy is capable of altering the course of acute infection.
As no specific therapy is capable of altering the course of acute hepatitis E infection, prevention is the most effective approach against the disease. Hospitalization is required for fulminant hepatitis and should be considered for infected pregnant women.